Literature DB >> 33335206

Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2.

Juliana C Ferreira1, Wael M Rabeh2.   

Abstract

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is responsible for the novel coronavirus disease 2019 (COVID-19). An appealing antiviral drug target is the coronavirus 3C-like protease (3CLpro) that is responsible for the processing of the viral polyproteins and liberation of functional proteins essential for the maturation and infectivity of the virus. In this study, multiple thermal analytical techniques have been implemented to acquire the thermodynamic parameters of 3CLpro at different buffer conditions. 3CLpro exhibited relatively high thermodynamic stabilities over a wide pH range; however, the protease was found to be less stable in the presence of salts. Divalent metal cations reduced the thermodynamic stability of 3CLpro more than monovalent cations; however, altering the ionic strength of the buffer solution did not alter the stability of 3CLpro. Furthermore, the most stable thermal kinetic stability of 3CLpro was recorded at pH 7.5, with the highest enthalpy of activation calculated from the slope of Eyring plot. The biochemical and biophysical properties of 3CLpro explored here may improve the solubility and stability of 3CLpro for optimum conditions for the setup of an enzymatic assay for the screening of inhibitors to be used as lead candidates in the discovery of drugs and design of antiviral therapeutics against COVID-19.

Entities:  

Year:  2020        PMID: 33335206     DOI: 10.1038/s41598-020-79357-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  9 in total

Review 1.  Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.

Authors:  Guo Liya; Wang Yuguang; Liu Jian; Yuan Huaiping; Han Xue; Huo Jianwei; Ma Jiaju; Lu Youran; Ming Chen; Jiao Yiqing
Journal:  APMIS       Date:  2020-06       Impact factor: 3.205

2.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

3.  [Characteristics of calcium and sodium transport in the synaptosomes and subsynaptosomal structures of the brain of spontaneously hypertensive rats].

Authors:  G M Kravtsov; S N Orlov; N I Pokudin; Iu V Postnov
Journal:  Kardiologiia       Date:  1982-11       Impact factor: 0.395

4.  Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.

Authors:  Zhenming Jin; Xiaoyu Du; Yechun Xu; Yongqiang Deng; Meiqin Liu; Yao Zhao; Bing Zhang; Xiaofeng Li; Leike Zhang; Chao Peng; Yinkai Duan; Jing Yu; Lin Wang; Kailin Yang; Fengjiang Liu; Rendi Jiang; Xinglou Yang; Tian You; Xiaoce Liu; Xiuna Yang; Fang Bai; Hong Liu; Xiang Liu; Luke W Guddat; Wenqing Xu; Gengfu Xiao; Chengfeng Qin; Zhengli Shi; Hualiang Jiang; Zihe Rao; Haitao Yang
Journal:  Nature       Date:  2020-04-09       Impact factor: 49.962

Review 5.  Origin and evolution of pathogenic coronaviruses.

Authors:  Jie Cui; Fang Li; Zheng-Li Shi
Journal:  Nat Rev Microbiol       Date:  2019-03       Impact factor: 60.633

6.  Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction.

Authors:  Xiaoyu Xue; Haitao Yang; Wei Shen; Qi Zhao; Jun Li; Kailin Yang; Cheng Chen; Yinghua Jin; Mark Bartlam; Zihe Rao
Journal:  J Mol Biol       Date:  2006-12-01       Impact factor: 5.469

Review 7.  Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics.

Authors:  Mansab Ali Saleemi; Bilal Ahmad; Khaled Benchoula; Muhammad Sufyan Vohra; Hing Jian Mea; Pei Pei Chong; Navindra Kumari Palanisamy; Eng Hwa Wong
Journal:  Infect Genet Evol       Date:  2020-10-06       Impact factor: 3.342

Review 8.  Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches.

Authors:  Magda Gioia; Chiara Ciaccio; Paolo Calligari; Giovanna De Simone; Diego Sbardella; Grazia Tundo; Giovanni Francesco Fasciglione; Alessandra Di Masi; Donato Di Pierro; Alessio Bocedi; Paolo Ascenzi; Massimo Coletta
Journal:  Biochem Pharmacol       Date:  2020-09-19       Impact factor: 5.858

Review 9.  The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.

Authors:  Jatin Machhi; Jonathan Herskovitz; Ahmed M Senan; Debashis Dutta; Barnali Nath; Maxim D Oleynikov; Wilson R Blomberg; Douglas D Meigs; Mahmudul Hasan; Milankumar Patel; Peter Kline; Raymond Chuen-Chung Chang; Linda Chang; Howard E Gendelman; Bhavesh D Kevadiya
Journal:  J Neuroimmune Pharmacol       Date:  2020-07-21       Impact factor: 7.285

  9 in total
  10 in total

1.  Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.

Authors:  Mohamed Haddad; Roger Gaudreault; Gabriel Sasseville; Phuong Trang Nguyen; Hannah Wiebe; Theo Van De Ven; Steve Bourgault; Normand Mousseau; Charles Ramassamy
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

2.  Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2.

Authors:  Juliana C Ferreira; Samar Fadl; Wael M Rabeh
Journal:  J Biol Chem       Date:  2022-05-11       Impact factor: 5.486

3.  Effect of pH on stability of dimer structure of the main protease of coronavirus-2.

Authors:  Panisak Boonamnaj; R B Pandey; Pornthep Sompornpisut
Journal:  Biophys Chem       Date:  2022-05-19       Impact factor: 3.628

4.  Surface cysteines could protect the SARS-CoV-2 main protease from oxidative damage.

Authors:  Raheleh Ravanfar; Yuling Sheng; Mona Shahgholi; Brett Lomenick; Jeff Jones; Tsui-Fen Chou; Harry B Gray; Jay R Winkler
Journal:  J Inorg Biochem       Date:  2022-06-02       Impact factor: 4.336

5.  Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study.

Authors:  Rahimasoom Reza; Tanmoy Dutta; Nabajyoti Baildya; Narendra Nath Ghosh; Abdul Ashik Khan; Rajesh Kumar Das
Journal:  Microb Pathog       Date:  2022-06-08       Impact factor: 3.848

6.  Structural Characterization and Binding Studies of the Ectodomain G Protein of Respiratory Syncytial Virus Reveal the Crucial Role of pH with Possible Implications in Host-Pathogen Interactions.

Authors:  Abu Hamza; Zoya Shafat; Zahoor Ahmad Parray; Malik Hisamuddin; Wajihul Hasan Khan; Anwar Ahmed; Fahad N Almajhdi; Mohamed A Farrag; Arif Ahmed Mohammed; Asimul Islam; Shama Parveen
Journal:  ACS Omega       Date:  2021-04-07

7.  A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition.

Authors:  Francesco Costacurta; Stephan Geley; Seyad Arad Mogadashi; Andre Volland; Emmanuel Heilmann; Bernhard Rupp; Reuben Stewart Harris; Dorothee von Laer
Journal:  Commun Biol       Date:  2022-04-27

8.  Design, synthesis and in silico screening of benzoxazole-thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases.

Authors:  Vijay Sai Krishna Cheerala; Prasanth Ghanta; Sundaresan Chittor Neelakantan
Journal:  RSC Adv       Date:  2021-12-10       Impact factor: 4.036

9.  Applying polypharmacology approach for drug repurposing for SARS-CoV2.

Authors:  Esther Jamir; Himakshi Sarma; Lipsa Priyadarsinee; Selvaraman Nagamani; Kikrusenuo Kiewhuo; Anamika Singh Gaur; Ravindra K Rawal; Natarajan Arul Murugan; Venkatesan Subramanian; G Narahari Sastry
Journal:  J Chem Sci (Bangalore)       Date:  2022-04-22

10.  Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.

Authors:  Juliana C Ferreira; Samar Fadl; Adrian J Villanueva; Wael M Rabeh
Journal:  Front Chem       Date:  2021-06-24       Impact factor: 5.221

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.